For our friends in India, we kindly suggest the following sessions at #DIA2013 in Boston, MA.

For our friends in India, we kindly suggest the following sessions at this year's annual meeting in Boston, MA.

Global Clinical Trials: The Role of Emerging Markets         

What are the areas of potential risks when undertaking global clinical trials in emerging markets?

GCPs in Emerging Countries

What are the GCP quality trends in US and emerging countries?
Partnering and Outsourcing Challenges in India: The New Paradigm Shifts
Partnering and #outsourcing in India: Strategies for integrating diverse skills around operational deliverables.
A Regulatory Perspective of Biosimilars in Emerging Markets
What are similarities/differences in biosimilar regulatory requirements in APAC and Latin America?


Sign up for DIA's Global SmartBrief eNews for the latest in drug development innovations worldwide.

Innovative Partnering Models and Outsourcing Strategies Track at DIA's 49th Annual Meeting

	How do you perform Quality Oversight of CROs - Clinical Vendors?
	What pitfalls are avoidable with strategic partnerships?
	Need to know best practices and latest trends in Regulatory Outsourcing Partnerships?
	Can a "virtual" R&D team model help you access the East Asian pharma market?
	What approaches are needed for transition from transactional to collaboration-based pharma outsourcing?
	How will future of sponsor-CRO partner relations impact the  pharma industry?
	Partnering and outsourcing in India: Strategies for integrating diverse skills around operational deliverables.
	How can Functional Service Providers help pharma industry drive improvement and innovation?
	What are challenges/successes in developing and maintaining Sponsor/ CRO Partnership?
	How can Collaboration make a better Global Trial?
	In what ways can the pharma industry manage risk in outsourced clinical trials?
	What are the Best Practices to Ensuring Strategic Sponsor/ CRO Collaboration Success?
	How does Project Data Sphere clinical trial data-sharing accelerates innovation and enhances patient health?
	Be better prepared to handle change orders in outsourcing. Join this brainstorming forum.
	How will mobile health level the playing field in global health?
	How do FDA collaborations broaden the reach of health care messages to the public?
	Thinking about Nonprofit-Industry Partnership to develop and/or disseminate new technology?

4th Pharmacovigilance Conference in Bangalore March 8-9

Register Today! The date of the 4th Pharmacovigilance Conference in India is fast approaching. Take this opportunity to discuss the latest global challenges in drug safety with professionals worldwide. Professionals attending the two-day conference, to be held in Bangalore from March 8-9, will learn about current global safety reporting requirements for prescription and over-the-counter drugs and discuss new, pragmatic approaches to pharmacovigilance. Other key topics will include the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan, and identifying best practices for quality assurance in post-marketing pharmacovigilance and clinical safety. Read More View Program Register EXHIBITING OPPORTUNITY Download the application for a tabletop display at the event. Other events of Interest Download the India Calendar of Events Conference Highlights Updates on recently released GPvP Modules by EMA Japanese model of EPPV – a way forward for other Asian countries Challenges in authoring PSUR for generic manufacturers An insight into Drug Induced Liver Injury (DILI) Global regulatory compliance: challenges and the way forward Safety regulations in emerging Middle East region Efficient management of literature searching Enhanced productivity and quality through process re-engineering; case studies Global outsourcing trends in PV – Indian potential and challenges by China, Taiwan, and Latin America RSI management – best practices to safeguard against pitfalls Attrition and manpower stability; KPO perspective Technology-watch against safety hazard of spurious and adulterated drugs Training; A Formality or a Reality – an industry insight Panel discussion: compensation for trial related injuries This Pharmacovigilance Conference is perfect for professionals with experience in clinical safety and who are involved in: Pharmacovigilance Clinical research Risk management Compliance Medical information Regulatory affairs Academia Pharmacology Read More View Program Register To know more, contact Manoj.Trivedi@diaindia.org Thank You to our Media Partner

Email Preferences | My DIA | Forward to a Friend |

New Insights into Current PV Challenges - March 8-9, 2013 Bangalore

Read more about the speakers and hot topics Check out the program for the 4th Pharmacovigilance Conference in India to find out more about this insightful event focusing on the latest global challenges in drug safety. Professionals attending this two-day conference, to be held in Bangalore from March 8-9, will learn about current global safety reporting requirements for prescription and over-the-counter drugs and discuss new, pragmatic approaches to pharmacovigilance. Other key topics will include the regulatory agency clinical safety and pharmacovigilance inspection program in the US, Europe, and Japan, and identifying best practices for quality assurance in post-marketing pharmacovigilance and clinical safety. Read More View Program Register EXHIBITING OPPORTUNITY Download the application for a tabletop display at the event. Other events of Interest Download the India Calendar of Events Conference Highlights Updates on recently released GPvP Modules by EMA Japanese model of EPPV – a way forward for other Asian countries Challenges in authoring PSUR for generic manufacturers An insight into Drug Induced Liver Injury (DILI) Global regulatory compliance: challenges and the way forward Safety regulations in emerging Middle East region Efficient management of literature searching Enhanced productivity and quality through process re-engineering; case studies Global outsourcing trends in PV – Indian potential and challenges by China, Taiwan, and Latin America RSI management – best practices to safeguard against pitfalls Attrition and manpower stability; KPO perspective Technology-watch against safety hazard of spurious and adulterated drugs Training; A Formality or a Reality – an industry insight Panel discussion: compensation for trial related injuries This Pharmacovigilance Conference is perfect for professionals with experience in clinical safety and who are involved in: Pharmacovigilance Clinical research Risk management Compliance Medical information Regulatory affairs Academia Pharmacology So make sure you save the date in your calendar for the 4th Pharmacovigilance Conference. Read More View Program Register To know more, contact Manoj.Trivedi@diaindia.org Thank You to our Media Partner

Email Preferences | My DIA | Forward to a Friend |